Associate Director, Advanced Analytics at Legend Biotech

Franklin Township, New Jersey, United States

Legend Biotech Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Master’s degree (preferred) or Bachelor’s degree in Statistics, Data Science, Computer Science, Mathematics, Econometrics, Public Health (with strong quantitative focus), or Pharmaceutical Sciences (with analytics specialization)
  • 7+ years in advanced analytics, data science, or commercial insights in pharma
  • Experience with pharma secondary data (e.g., IQVIA, Symphony, DRG)
  • Strong statistical modeling and multivariate analysis skills: Regression (linear, logistic, multivariate), Classification and clustering algorithms, Time series forecasting, Ensemble methods (e.g., random forests, gradient boosting), Neural networks and deep learning (optional but valuable)
  • Ability to communicate complex analytics to non-technical stakeholders
  • Experience in commercial pharma strategy, especially in Sales, Marketing, or Market Access
  • Ability to act as a strategic partner to Insights & Analytics leadership
  • Familiarity with brand planning, launch strategy, and lifecycle management
  • Proficiency in Python and R for statistical computing and modeling
  • SQL for data extraction and manipulation
  • Familiarity with Snowflake, Databricks, or other cloud data platforms
  • Familiarity with machine learning libraries

Responsibilities

  • Lead advanced analytics projects using sales, claims, and prescriber-level data
  • Develop predictive models to identify growth drivers and risks
  • Apply regression, clustering, and machine learning techniques
  • Collaborate with cross-functional teams to embed analytics into decision-making
  • Present findings to senior leadership and guide strategic planning
  • Stay current with emerging analytics tools and methodologies
  • Work independently to make decisions related to technical direction, methodologies, and approaches to address key business questions
  • Collaborate with cross-functional teams and align with Manager on identification of key business questions and priorities

Skills

Machine Learning
Statistical Modeling
Regression
Clustering
Predictive Modeling
Multivariate Techniques
Pharma Data Analysis

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters
2014Year Founded
$146.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Sick Leave
Paid Holidays
Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI